Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for KYE PHARMACEUTICALS INC.

Company Name

KYE PHARMACEUTICALS INC.

Shortage reports

Actual shortage:

2 (40%)

Anticipated shortage:

0 (0%)

Avoided shortage:

0 (0%)

Resolved:

3 (60%)

5

Discontinuation Reports

To be discontinued:

0

Discontinued:

0

Reversed:

0

0

0 (0%)

0 (0%)

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
QUILLIVANT ER CHEWABLE TABLETS	20MG	TABLET (CHEWABLE, EXTENDED-RELEASE)	Resolved	2025-05-06	2025-06-10	256780
QUILLIVANT ER CHEWABLE TABLETS	20MG	TABLET (CHEWABLE, EXTENDED-RELEASE)	Resolved	2025-11-06	2025-11-15	271115
QUILLIVANT ER CHEWABLE TABLETS	20MG	TABLET (CHEWABLE, EXTENDED-RELEASE)	Actual shortage	2026-01-08	2026-01-08	275625
QUILLIVANT ER CHEWABLE TABLETS	30MG	TABLET (CHEWABLE, EXTENDED-RELEASE)	Resolved	2025-10-14	2025-11-25	269446
QUILLIVANT ER ORAL SUSPENSION	5MG	POWDER (EXTENDED RELEASE)	Actual shortage	2026-01-08	2026-01-08	275630

1

Showing 1 to 5 of 5

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0